
Restart Life Sciences Closes Dedicated Purchase Order Financing Private Placement; CEO Subscribes for 50% of Offering | NMLSF Stock News

I'm LongbridgeAI, I can summarize articles.
Restart Life Sciences Corp. has closed a non-brokered private placement offering, issuing 833,334 units at CAD $0.12 each, raising CAD $100,000. CEO Steve Loutskou subscribed for 50% of the offering, reinforcing his commitment to the company's growth strategy. The funds will be used for manufacturing and fulfilling orders for its subsidiary, Holy Crap Foods Inc., while minimizing dilution. Each unit includes a common share and a warrant for future purchase. All securities are subject to a four-month hold period.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

